Here are some note worthy news pieces showing the
general development of Priligy®
/ Dapoxetine.
It is not our intention to follow every single news
story
that ever mentions this drug, but rather give an indication
of
a time line from its early beginnings of what has
happened with Priligy®
/ Dapoxetine to what is happening
today with its development. Please note
these news
pieces are pharaphrased and maybe brief in content in
order to provide a quick overview.
July 16th, 2003
It
is announced that dapoxetine is going to go ahead with phase three investigations
for the treatment of premature ejaculation.
December 3rd,
2003
PPD, Inc. announced that today it would be acquiring from Eli Lilly
the rights for the compound dapoxetine. PPD will pay Lilly $65 million dollars
for this accusition as well as pay a percentage of any profits made. Previously
it was made known that PPD had in-licensed dapoxetine back in 1998 from Lilly,
developed it, then licensed it out to ALZA Corp (owned subsidiary of Johnson
and Johnson) back in 2001. PPD and Lilly have ended their old licensed agreement
regarding this substance. Currently dapoxetine is in phase three testing for
premature ejaculation.
|
